UK to partner with Israel, US, China to combat infectious diseases

Many devastating diseases have proved able to infect humans, including Zika, Ebola, African Swine Fever and Anthrax.

UK Research and Innovation (UKRI), will partner with experts from Israel, the US and China to study the evolution and transmission of infectious diseases.

The joint project will examine the interaction between humans, livestock, crops, wild animals and plants, which can lead to the spreading of diseases.

UKRI has declared that it will contribute £8.3 million ($10.2m.) to the joint research project. The agency also revealed new collaborative projects with Chinese researchers to create products and services to help the elderly.

Participants with UKRI to combat infectious diseases will be the US-Israel Binational Science Foundation, the National Science Foundation (NSF), the National Institutes of Health (NIH), the US Department of Agriculture (USDA) and the National Natural Science Foundation of China (NSFC).

Understanding, predicting and mitigating complex interactions between humans and other species, will improve the ability to forecast and manage outbreaks, generate new cost-effective prevention and control methods, and enhance food safety and public health. The project focuses to hire researchers with mathematical and computational expertise, in addition to a range of social scientists and life scientists.

For our part at Innovation UK did a prioritization exercise. They looked at countries with very strong capabilities, complementary capabilities that we would like to partner with. Israel was one of those countries.

The latest strategy for international research and innovation, emphasizes the United Kingdom’s need to play its part in confronting global challenges as an “outward-looking nation,” collaborating with researchers wherever they may be, in Europe or beyond.

Israel is called a technology hub and there is a clear realization that the UK needs to collaborate with the best and work to facilitate that collaboration.